📰 Iagnostics News
Page 142 - Iagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iagnostics. Real-time updates on events, politics, business and more.
May 25, 2021
MedCity News Truepill becomes a ‘triple threat’ with diagnostics Truepill, the company operating behind-the-scenes to help digital health companies with pharmacy fulfillment and telehealth visits, has added a third feature: at home testing. CEO Umar Afridi hopes the trio of services will create a seamless experience for most people’s basic health needs. Shares0 Truepill, a company operating behind-the-scenes of several well-known digital health brands and health plans, added another too...
May 25, 2021
(0) - Treatment informed by Axumin PET imaging significantly improved event-free-survival for men with recurrent prostate cancer at three and four years - - Winship Cancer Institute of Emory Universitys EMPIRE-1 trial is first-of-its-kind randomized patient outcomes study of amino acid PET imaging in influencing a cancer control endpoint - Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, is pleased to...
May 24, 2021
Washington [US], May 24 (ANI): A new study on COVID patients has found that abnormal blood-oxygen levels and breathing rates are strong predictors of poor patient outcomes in hospitals.
May 24, 2021
An international research collaboration led by the University of Tsukuba have used Raman microspectroscopy and Raman imaging to detect changes in the elastic and collagen fibers in the aortic wall characteristic of ascending thoracic aortic aneurysms (aTAAs). This has the potential to be used as a low-risk, early diagnostic tool to detect pre-aneurysmal lesions before serious complications develop.
May 20, 2021
E-Mail IMAGE: Schematic of the co-planar light-actuated optoelectrowetting microfluidic device that features an integrated metal mesh grid. A droplet on the device surface is actuated and moved around the two-dimensional plane under... view more Credit: Jodi Loo et al. doi: 10.1117/1.JOM.1.3.034001. Microfluidic technologies have seen great advances over the past few decades in addressing applications such as biochemical analysis, pharmaceutical development, and point-of-care diagno...
May 17, 2021
Rice University researchers have engineered a bacterium capable of diagnosing a human disease, a milestone in the field of synthetic biology.
May 17, 2021
Ontario-based, Nicoya Lifesciences, is in the process of completing a prototype of a low-cost, single-use device that tests for active SARS-CoV-2 infection, variants and, eventually, other viruses. The novel test is called Atlas. Users administer the Atlas test themselves with a simple saliva collection kit. After that, a smartphone application provides results, in only 20 minutes – without complex lab equipment or highly trained technicians. Atlas was develop...
May 15, 2021
Diagnostics that can identify biomarkers of disease in the blood are helping speed drug trials for intractable conditions like Alzheimer's.Why it matters: Blood biomarker diagnostics can help pharmaceutical companies identify the right patients to enroll in drug trials for difficult-to-diagnose neurological conditions without resorting to more expensive and invasive methods like brain scans or spinal taps.Get market news worthy of your time with Axios Markets. Subscribe for free.Driving the...
May 14, 2021
Credit: Dr Amelia Wesselink Higher levels of ozone from air pollution are linked to an increased risk of developing fibroids among Black American women according to a large study published today (Friday) in Human Reproduction [1], one of the worlds leading reproductive medicine journals. Fibroids are non-cancerous growths that develop in and around the womb. They are diagnosed in 25-30% of pre-menopausal women, but the true incidence is thought to be between 70-80%. Many fibroids do not cause ...
May 14, 2021
Antibodies generated by malaria cross-react with SARS-CoV-2 An international team of researchers has warned that individuals with acute malaria infection generate high levels of antibodies that cross-react with the viral spike protein of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19). The spike protein is the main structure the virus uses to bind to and infect host cells and the primary target of neutralizing antibodies fol...